Randomized Controlled Trial of Early Intensive Leg Exercise to Improve Walking in Children With Diplegia
Launched by UNIVERSITY OF ALBERTA · Sep 13, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a special program of intensive leg exercises can help improve walking in young children who have spastic diplegia, a condition that affects movement in both legs. The trial compares this exercise program to standard physiotherapy care over three months to see which approach works better for helping children move more easily.
To be eligible for this trial, children should be between 2 to 3 years old and have some difficulty using their legs but can stand with some support. They should also have experienced a specific type of brain injury related to being born prematurely. However, children with serious problems using their arms or those who have had certain medical issues recently may not be able to participate. If a child joins the trial, they will be part of a group that either does the intensive exercises or receives standard care, and both groups will be monitored to see how their walking improves. This trial aims to provide valuable information that could help many children with similar conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Bilateral motor impairment of the lower extremities
- • Periventricular white matter injury from encephalopathy of prematurity
- • Able to stand with some support
- Exclusion Criteria:
- • Substantial upper extremity involvement - Manual Abilities Classification System (MACS) Level ≥3
- • Uncontrolled epilepsy or infantile spasms in the past 6 months
- • Cardiovascular or musculoskeletal complications that preclude participation in intensive exercise
- • Botulinum toxin-A (BTX-A) injections in the legs in the last 6 months
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Edmonton, Alberta, Canada
Patients applied
Trial Officials
Jaynie Yang, Phd
Principal Investigator
Universtiy of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials